Snap Inc plans to publicly file for its IPO this week, which means the company will likely go public in March, recode is reporting. Snap has already filed confidentially with the SEC. Morgan Stanley and Goldman Sachs are leading the IPO, the story said. A valuation for Snap could reach $25 billion, recode said.
1 min read · 30 January 2017
1 min read · 27 January 2017
1 min read · 26 January 2017
Warburg Pincus has made a growth investment in Nexera Holding LLC. Financial terms weren’t announced. Nexera, of Emeryville, California, is a residential mortgage lender.
3 min read · 26 January 2017
McKesson Corp. said Jan. 25 that it has agreed to buy CoverMyMeds for about $1.1 billion. The deal includes another $300 million of consideration contingent upon CoverMyMeds financial performance through fiscal 2019, McKesson said. CoverMyMeds, of Columbus, Ohio, is a healthcare software company backed by Francisco Partners.
3 min read · 26 January 2017
Rubicon Technology Partners has invested in Gimmal. Financial terms weren’t announced. Gimmal, of Houston, provides information management software. Mooreland Partners served as financial advisor to Gimmal.
2 min read · 26 January 2017
Teachable said Jan. 25 that it closed a $4 million round of funding led by Accomplice Ventures. Other participants include Naval Ravikant and Matt Brezina. Teachable, of New York, is a online course creation platform that connects instructors with students.
2 min read · 26 January 2017
VITAC Corp said Jan. 25 that it acquired Caption Colorado. Financial terms weren’t announced. Caption Colorado, of Greenwood Village, Colorado, provides captioning services. VITAC is a Gores Group portfolio company.
3 min read · 26 January 2017
Dermatology Associates, a portfolio company of ABRY Partners, said Jan. 25 that it acquired Austin DermCare. Financial terms weren’t announced. Austin DermCare, of Austin, Texas, provides clinical, surgical and cosmetic services.
3 min read · 25 January 2017
Connect Biopharmaceuticals Ltd said Jan. 25 that it completed a $20 million Series A financing led by Qiming Venture Partners. Also participating were Northern Light Venture Capital, Lapam Capital and Cowin Venture Capital. Connect Biopharmaceutical, of Taicang, Suzhou, is a clinical-stage company that discovers and develops immune modulators for the treatment of inflammation and cancer.
5 min read · 25 January 2017